Replicate Bioscience is applying advanced srRNA technology towards solving a life-threatening problem—drug resistance in cancers—using their proprietary synthetic immune lethality approach. They are also developing srRNA injections for sustained therapeutic protein expression, to treat inflammatory disorders and other conditions.

Biotechnology

Replicate Bioscience

Replicate Bioscience's headquarters in San Diego, CA, United States

Nathaniel Wang

Parinaz (Paris) Aliahmad

Andrew Geall

Michael Ehlers

Seth L. Harrison

Joseph A. Yanchik III

Philip Santangelo

Mohit Trikha

Jeffrey Ulmer

The Research and Development Team at Replicate Bioscience is dedicated to advancing the company's mission of combating drug-resistant cancers and treating inflammatory disorders through cutting-edge srRNA technology. The team focuses on developing and optimizing proprietary synthetic immune lethality approaches and srRNA injections for sustained therapeutic protein expression, conducting rigorous scientific research, and translating innovative discoveries into clinical applications.

Research and Development Team

The Leadership Team at Replicate Bioscience drives strategic direction and oversees the execution of the company's mission to combat drug-resistant cancers and inflammatory disorders. Comprising the founders and key executives, this team collaborates on innovative product development, operational excellence, and securing partnerships to advance their proprietary srRNA technology and therapeutic innovations.

Leadership Team

The Directors Team at Replicate Bioscience provides strategic leadership and oversight, ensuring alignment with the company's mission to combat drug resistance in cancers using advanced srRNA technology. They are responsible for high-level decision-making, resource allocation, and fostering innovation in the development of therapeutic solutions for inflammatory disorders and other conditions.

Directors Team

The Medical and Scientific Team at Replicate Bioscience focuses on advancing the company's proprietary srRNA technology to address drug resistance in cancers and develop sustained therapeutic protein expression treatments. This team, which includes the Chief Medical Officer and experts in compound development and immuno-oncology, drives clinical strategy, oversees laboratory research, and ensures the scientific integrity of therapeutic innovations.

Replicate Bioscience

Org chart

Board & advisors

Teams

Research and Development Team

Leadership Team

Directors Team

Medical and Scientific Team

Offices

Replicate Bioscience

Org chart

Board & advisors

Teams

Research and Development Team

Leadership Team

Directors Team

Medical and Scientific Team

Offices

Related companies